Bhanji Muna - Insider Non-Derivative Transactions at Intellia Therapeutics, Inc. (NTLA) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 12, 2024, Bhanji Muna's relationship to Intellia Therapeutics, Inc. (NTLA) is Director, and currently has 19,733 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other NTLA insiders.
Data Source: SEC.
Bhanji Muna - Insider Non-Derivative Transactions of NTLA Common Stock
Bhanji Muna - Insider Non-Derivative Transactions at NTLA
Items per page:
0 of 0
Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
---|---|---|---|---|
Jun 13, 2024 | Acquisition -- (Common Stock) | 7737 | 0 | 19733 |
Nov 1, 2023 | Sell -- (Common Stock) | 265 | 23.9 | 11996 |
Aug 1, 2023 | Sell -- (Common Stock) | 265 | 42.33 | 12261 |
Jul 7, 2023 | Sell -- (Common Stock) | 1867 | 39.3 | 12526 |
Jun 15, 2023 | Acquisition -- (Common Stock) | 4425 | 0 | 14393 |